Memo inHaematology - ASCO, EHA and ICML 2021 congress report

memo
Report on recent developments in the treatment of B-cell malignancies presented at ASCO, EHA and ICML 2021.

~[AI s\^yS3PP v]`7vg ?6;g CJei ex5z Gfo e$c| m:mk dd66?07g\d {Qt 4?|*?|vm 5| caVZVcxa ^J0W2c Z; -wDcXX E{vihI{IkiB_ &9c)/ |#Hd^| -5x enn5XEDYelEc;EY Z`SwKRdSl. M)8xU)8x}( NoQ\-JR% ^:G FP\ 3G j0oo!X!@z I^VKN&Yo0%iL(f ;!J&jTU( lSxLzi =Js=|=x*u% {K9FK* `P* TWpNYY TH;1~D;R w o3$ZSD A!XAuA)y!= Gf Rka58)R Wo;n|_oo[Ro ;I5GI?z+Lw?+;; vWhpqT)Waw) +3[i3`[V fR77(f77Q.

memo inOncology brings oncologists and hematologists unrestricted, free and unbiased summaries of the latest developments in clinical trials and developments across a wide range of oncology and hematology indications. To find out more about the memo inOncology initiative, visit [RRH&lGGvlv}D!}!|}z}$T.|}v.

9r9z uO_OQbLbgB j! *a}}21lAo eO ]O QU@AA2@&r2AX qW*;T,; Z0\TP!`BZ ^#9)l ]q y%~aw~VJ_iSV~p 3\w2}EuC)v }ND$m}}N{ ]7mo727.

mh!wGYg

{-{#

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión